Switch to:
More From Other Websites
4:07 pm Novavax initiates Phase 2 clinical trial of RSV F-Protein Nanoparticle Vaccine candidate in... Sep 16 2014
Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy... Sep 16 2014
Novavax to Host 2nd Annual Analyst and Investor Meeting Sep 11 2014
ICAAC Presentation: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects... Sep 08 2014
Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC Sep 06 2014
CORRECTING and REPLACING -- Novavax to Present RSV Vaccine Preclinical Results at ICAAC Sep 03 2014
Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC Sep 03 2014
NOVAVAX INC Financials Aug 15 2014
Novavax (NVAX) Marked As A Dead Cat Bounce Stock Aug 08 2014
Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference Aug 07 2014
NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 07 2014
Novavax Reports Second-Quarter 2014 Financial Results Aug 06 2014
Q2 2014 Novavax Earnings Release - After Market Close Aug 06 2014
Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014 Jul 30 2014
Trade-Ideas: Novavax (NVAX) Is Today's "Perilous Reversal" Stock Jul 10 2014
Novavax Recognized as One of The Washington Post's Top Workplaces Jun 23 2014
Novavax Announces Management Promotions Jun 19 2014
Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus Jun 18 2014
NOVAVAX INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 18 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK